You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

Chemotherapy

The guidelines and other documents available here provide recommendations on safe and effective chemotherapy for people with cancer in Ontario.

Displaying Guidelines

13 Items

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Document Status: Current
ID: GL-7-A-2016-3

Apr 2017

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Document Status: In-Review
ID: 7-14
Version: 3

Dec 2018

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Document Status: In-Review
ID: 7-13

Oct 2017

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Document Status: Archived
ID: CED 21

Jan 2011

Postoperative Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer: Guidance for Nurses

Document Status: Archived
ID: 7-1-2N

Dec 2007

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Document Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Lung Cancer

Document Status: Archived
ID: 7-19

Oct 2012

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours

Document Status: Current
ID: 7-11
Version: 3

Mar 2022

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Document Status: Current
ID: 7-A-2022-1-17v3
Version: 3

Oct 2023

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-3

Feb 2021

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020